Jun 2026 (Q3 FY26) — Aug 5, 2026
Clearfield Q3 FY26 — Hyperscale Data Center Win Offsets Broadband Headwinds and Guidance Cut
Read the full callClearfield (CLFD) earnings
- Jun 2026
- Jun 2026 (Q3 FY26)
- Sep 2025
Clearfield earnings: last reported Wed, 5 Aug 2026, for the quarter ended Jun 2026.
Reported
The figures, each with its period
Each figure keeps its basis and period; nothing is filled in.
| Metric | Value | Change | Basis | Period | Note |
|---|---|---|---|---|---|
| Revenue | 43.9 | +13.2% YoY | Quarterly, as filed | Quarter to Jun 2026 | Revenue from operations as filed. |
| Operating margin | 5.9 | +1.9 pts YoY | Operating profit / revenue | Quarter to Jun 2026 | For the quarter; a change is in percentage points. |
| Net profit | 3.0 | +86.8% YoY | Quarterly, as filed | Quarter to Jun 2026 | Profit after tax as filed. |
Price
$30.6 +3.83% · +$1.13
Performance −11.5% 1Y
1Y: $34.56 on 17 Oct 2025 → $30.6. High $51.26 (27 May 2026), low $26 (7 Apr 2026).
- Previous close
- $29.47
- 52-week range
- $26 – $51.26
- One year
- −12.92%
Overview
- Symbol
- CLFD
- Sector
- Information Technology
- Exchange
- US
- Currency
- USD
Call summaries
Every analysed call
Clearfield earnings calls (CLFD)
Financials
What the filings say
Net profit, year on year: +87% (quarter to jun 2026 against jun 2025).
| Line item | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|
| Sales | 47 | 30 | 41 | 39 | 18 | 34 | 34 | 44 |
| Operating profit | -3 | -2 | 2 | 2 | 4 | -2 | -2 | 3 |
| Operating margin | −6.4% | −6.9% | 4.1% | 3.9% | 24.6% | −5.3% | −6.0% | 5.9% |
| Interest | 0 | 0 | 0 | 0 | — | — | — | — |
| Profit before tax | -1 | -0 | 3 | 3 | 6 | -0 | -1 | 4 |
| Tax rate | 37.3% | −17.6% | 22.1% | 25.3% | 15.3% | 0.4% | 25.0% | 23.7% |
| Net profit | -1 | -2 | 1 | 2 | -9 | -1 | -1 | 3 |
| EPS ($ per share) | — | -0.13 | 0.09 | 0.11 | — | -0.04 | -0.04 | 0.22 |
| Line item | Sep 2018 | Sep 2019 | Sep 2020 | Sep 2021 | Sep 2022 | Sep 2023 | Sep 2024 | Sep 2025 |
|---|---|---|---|---|---|---|---|---|
| Equity capital | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Reserves | 13 | 18 | 25 | 45 | 95 | 127 | 115 | 107 |
| Total liabilities | 5 | 7 | 13 | 22 | 82 | 40 | 40 | 50 |
| Fixed assets | 5 | 5 | 5 | 5 | 18 | 22 | 16 | 10 |
| Investments | 9 | 14 | 11 | 10 | 6 | 130 | 115 | 84 |
| Total assets | 74 | 82 | 95 | 126 | 229 | 356 | 315 | 306 |
| Line item | Sep 2018 | Sep 2019 | Sep 2020 | Sep 2021 | Sep 2022 | Sep 2023 | Sep 2024 | Sep 2025 |
|---|---|---|---|---|---|---|---|---|
| Cash from operations | 5 | 15 | 7 | 11 | 2 | 18 | 22 | 27 |
| Cash from investing | -13 | -13 | -0 | -14 | -8 | -112 | -7 | — |
| Cash from financing | -2 | -0 | -0 | -1 | 9 | 115 | -37 | — |
| Net cash flow | — | 2 | 6 | -3 | 3 | 21 | -22 | 6 |
| Capital expenditure | -1 | -3 | -2 | -2 | -8 | -8 | -10 | -5 |
| Free cash flow | 3 | 12 | 5 | 9 | -6 | 11 | 13 | 22 |
Insider filings
49 filings between Nov 16, 2025 and Jul 1, 2026.
Open market
decisions to buy or sellPurchases
$300.6K
1 purchase by 1 insider
Sales
$1.15M
8 sales by 4 insiders
63% filed under a 10b5-1 plan — scheduled in advance, not decided on the day
Compensation
not trading decisions- 26
- Award — granted as compensation
- 13
- Tax withheld — shares kept back by the company to cover tax
Also filed: 1 gift.
Who traded
open market only| Insider | Bought | Sold | Last filing |
|---|---|---|---|
| Beranek Cheryl | — | $862.0K | Jul 1, 2026 |
| ROTH RONALD G | $300.6K | — | Dec 15, 2025 |
| Hayward Donald R. | — | $115.0K | Feb 19, 2026 |
| Jones Walter Louis JR | — | $110.1K | May 11, 2026 |
| Khemakhem Anis | — | $67.2K | Jun 9, 2026 |
Latest filings (50)
| Date | Insider | What | Shares | Value |
|---|---|---|---|---|
| Jul 1, 2026 | Beranek Cheryl Chief Executive Officer | Sale 10b5-1 plan | 1,778 | $71.2K |
| Jun 30, 2026 | Hill John P Chief Operating Officer | Award | 459 | $11.4K |
| Jun 30, 2026 | Khemakhem Anis Chief Commercial Officer | Award | 158 | $3.9K |
| Jun 30, 2026 | HERZOG DANIEL R Chief Financial Officer | Award | 752 | $18.6K |
| Jun 30, 2026 | Beranek Cheryl Chief Executive Officer | Award | 210 | $5.2K |
| Jun 9, 2026 | Khemakhem Anis Chief Commercial Officer | Sale | 1,684 | $67.2K |
| Jun 1, 2026 | Beranek Cheryl Chief Executive Officer | Sale 10b5-1 plan | 7,500 | $351.9K |
| May 27, 2026 | Beranek Cheryl Chief Executive Officer | Sale 10b5-1 plan | 2,500 | $125.0K |
| May 11, 2026 | Beranek Cheryl Chief Executive Officer | Sale 10b5-1 plan | 2,500 | $112.6K |
| May 11, 2026 | Jones Walter Louis JR Director | Sale | 2,391 | $110.1K |
| May 8, 2026 | Beranek Cheryl Chief Executive Officer | Sale 10b5-1 plan | 5,000 | $201.4K |
| May 6, 2026 | Khemakhem Anis Chief Commercial Officer | Tax withheld | 635 | $19.2K |
| Feb 27, 2026 | Wirsbinski Carol Ann Director | Award | 2,544 | $0 |
| Feb 27, 2026 | Seidel Rebecca Director | Award | 2,544 | $0 |
| Feb 27, 2026 | ROTH RONALD G Director | Award | 2,544 | $0 |
| Feb 27, 2026 | SKARVAN KATHLEEN Director | Award | 2,544 | $0 |
| Feb 27, 2026 | Sarcevic Ademir Director | Award | 2,544 | $0 |
| Feb 27, 2026 | Jones Walter Louis JR Director | Award | 2,544 | $0 |
| Feb 27, 2026 | Kelly Catherine T. Director | Award | 2,544 | $0 |
| Feb 19, 2026 | Hayward Donald R. Director | Sale | 3,595 | $115.0K |
| Dec 31, 2025 | Hill John P Chief Operating Officer | Award | 222 | $5.5K |
| Dec 31, 2025 | HERZOG DANIEL R Chief Financial Officer | Award | 88 | $2.2K |
| Dec 31, 2025 | Beranek Cheryl Chief Executive Officer | Award | 210 | $5.2K |
| Dec 31, 2025 | Khemakhem Anis Chief Commercial Officer | Award | 131 | $3.2K |
| Dec 15, 2025 | ROTH RONALD G Director | Purchase | 10,000 | $300.6K |
| Dec 11, 2025 | Beranek Cheryl Chief Executive Officer | Gift | 1,960 | $0 |
| Dec 10, 2025 | Seidel Rebecca Director | Award | 326 | $0 |
| Dec 10, 2025 | SKARVAN KATHLEEN Director | Award | 326 | $0 |
| Nov 28, 2025 | Hill John P Chief Operating Officer | Award | 17,030 | $0 |
| Nov 28, 2025 | Beranek Cheryl Chief Executive Officer | Award | 25,545 | $0 |
| Nov 28, 2025 | HERZOG DANIEL R Chief Financial Officer | Award | 11,495 | $0 |
| Nov 20, 2025 | Hill John P Chief Operating Officer | Award | 10,788 | $0 |
| Nov 20, 2025 | Hill John P Chief Operating Officer | Tax withheld | 2,653 | $74.9K |
| Nov 20, 2025 | Beranek Cheryl Chief Executive Officer | Tax withheld | 2,653 | $74.9K |
| Nov 20, 2025 | Beranek Cheryl Chief Executive Officer | Award | 5,393 | $0 |
| Nov 20, 2025 | Beranek Cheryl Chief Executive Officer | Award | 10,788 | $0 |
| Nov 20, 2025 | HERZOG DANIEL R Chief Financial Officer | Award | 2,696 | $0 |
| Nov 20, 2025 | HERZOG DANIEL R Chief Financial Officer | Award | 5,394 | $0 |
| Nov 20, 2025 | HERZOG DANIEL R Chief Financial Officer | Tax withheld | 824 | $23.3K |
| Nov 20, 2025 | Hill John P Chief Operating Officer | Award | 5,393 | $0 |
| Nov 16, 2025 | HERZOG DANIEL R Chief Financial Officer | Tax withheld | 510 | $15.7K |
| Nov 16, 2025 | HERZOG DANIEL R Chief Financial Officer | Tax withheld | 973 | $29.9K |
| Nov 16, 2025 | HERZOG DANIEL R Chief Financial Officer | Tax withheld | 825 | $25.3K |
| Nov 16, 2025 | Hill John P Chief Operating Officer | Tax withheld | 2,017 | $62.0K |
| Nov 16, 2025 | Beranek Cheryl Chief Executive Officer | Tax withheld | 1,020 | $31.3K |
| Nov 16, 2025 | Beranek Cheryl Chief Executive Officer | Tax withheld | 1,948 | $59.8K |
| Nov 16, 2025 | Beranek Cheryl Chief Executive Officer | Tax withheld | 2,318 | $71.2K |
| Nov 16, 2025 | Hill John P Chief Operating Officer | Tax withheld | 1,020 | $31.3K |
| Nov 16, 2025 | Hill John P Chief Operating Officer | Tax withheld | 2,653 | $81.5K |
| Sep 18, 2025 | Hill John P Chief Operating Officer | Tax withheld | 14,000 | $478.9K |
Source: SEC Form 4 filings. Form 4 reports transactions, not the cap table — absence of filings says nothing about how much an insider owns, and a quiet window is not a signal.
Your own record
Start an Inve Case for Clearfield, Inc.
Free account. Everything above stays public.
Write why you follow Clearfield, Inc. and the condition you want checked. Inve compares your numeric conditions with available results and management guidance; your own conditions remain yours to review.
Keep reading